4A9N
N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH N-cyclopropyl-5-(3,5- dimethyl-1,2-oxazol-4-yl)-2-methylbenzene-1-sulfonamide
Summary for 4A9N
Entry DOI | 10.2210/pdb4a9n/pdb |
Related | 1X0J 2YDW 2YEK 4A9E 4A9F 4A9H 4A9I 4A9J 4A9M 4A9O 4A9P |
Descriptor | BROMODOMAIN CONTAINING 2, 1,2-ETHANEDIOL, N-CYCLOPROP-2-EN-1-YL-5-(3,5-DIMETHYL-1,2-OXAZOL-4-YL)-2-METHYL-BENZENESULFONAMIDE, ... (6 entities in total) |
Functional Keywords | signaling protein-inhibitor complex, signaling protein/inhibitor |
Biological source | HOMO SAPIENS (HUMAN) |
Total number of polymer chains | 3 |
Total formula weight | 55169.70 |
Authors | Chung, C.,Bamborough, P. (deposition date: 2011-11-26, release date: 2012-02-08, Last modification date: 2019-05-08) |
Primary citation | Bamborough, P.,Diallo, H.,Goodacre, J.D.,Gordon, L.,Lewis, A.,Seal, J.T.,Wilson, D.M.,Woodrow, M.D.,Chung, C.W. Fragment-Based Discovery of Bromodomain Inhibitors Part 2: Optimization of Phenylisoxazole Sulfonamides. J.Med.Chem., 55:587-, 2012 Cited by PubMed: 22136469DOI: 10.1021/JM201283Q PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.85 Å) |
Structure validation
Download full validation report